Literature DB >> 3943191

Thrombin clotting activity measurement and standardization with lyophilized plasma.

J W Fenton, C S Wideman, B L Evatt.   

Abstract

Thrombin-induced clotting times were inversely proportional to fibrinogen concentrations within the range of 98 to 2900 nmol/L; these reciprocal velocity measurements had units of seconds per clot. By analogy with classical enzyme kinetics, we defined rectangular hyperbolic parameters where Km(clot) ranged from 0.14 to 0.56 mumol/L and kclot from 0.020 to 0.075 clot per second. Specificity ratios (kclot/Km(clot)) showed that reconstituted lyophilized human plasma is as good, if not better, a source of clottable fibrinogen as the purified protein itself. These ratios also showed that the presence of greater than 98% of the autoproteolytic forms (beta- and gamma-thrombins) of the human enzyme did not interfere with clotting activity attributable to alpha-thrombin. Contrary to simple enzyme kinetics, velocities (reciprocal clotting times) were rectangular hyperbolically related to clotting activities. Clotting times between 5 and 90 s/clot correlated (r greater than 0.999) with reciprocal alpha-thrombin concentrations, permitting standardization with lyophilized plasma (1000 U.S. "NIH" thrombin-clotting units/L corresponded to approximately 21 s/clot with these plasma). Lyophilized plasma re-examined after 15 months displayed no change in clottability.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3943191

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  2 in total

1.  Rapid purification of high purity thrombin and preparation of a novel hemostat for clinical purposes.

Authors:  Krishna Kumar Turaga; P Chakradhara Rao; G Sripad
Journal:  Indian J Hematol Blood Transfus       Date:  2008-08-24       Impact factor: 0.900

2.  Thrombin-specific inhibition by and slow cleavage of hirulog-1.

Authors:  J I Witting; P Bourdon; D V Brezniak; J M Maraganore; J W Fenton
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.